{
  "trial_id": "NCT00424021",
  "trial_group": "hypertension",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, sex, race, baseline pulmonary arterial hypertension (PAH) severity, baseline exercise capacity, baseline functional class, baseline hemodynamic parameters, baseline use of PAH-specific therapies, baseline comorbidities, baseline HIV status, baseline conventional therapy for PAH, baseline laboratory values, baseline vital signs, baseline echocardiographic parameters.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race/Ethnicity",
          "race"
        ],
        [
          "Years Pulmonary Arterial Hypertension (PAH) Present",
          "baseline pulmonary arterial hypertension (PAH) severity"
        ],
        [
          "6-minute Walk Distance",
          "baseline exercise capacity"
        ],
        [
          "World Health Organization Class",
          "baseline functional class"
        ],
        [
          "Primary Diagnosis",
          "baseline comorbidities"
        ],
        [
          "Height",
          "baseline vital signs"
        ],
        [
          "Weight",
          "baseline vital signs"
        ]
      ],
      "remaining_reference_features": [
        "Borg Dyspnea Index"
      ],
      "remaining_candidate_features": [
        "Age",
        "baseline hemodynamic parameters",
        "baseline use of PAH-specific therapies",
        "baseline HIV status",
        "baseline conventional therapy for PAH",
        "baseline laboratory values",
        "baseline echocardiographic parameters"
      ]
    }
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Baseline PAH severity, HIV status, Concomitant PAH therapy, Duration of PAH diagnosis,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Race/Ethnicity",
          "Race/Ethnicity"
        ],
        [
          "Years Pulmonary Arterial Hypertension (PAH) Present",
          "Duration of PAH diagnosis"
        ],
        [
          "Primary Diagnosis",
          "Baseline PAH severity"
        ],
        [
          "World Health Organization Class",
          "HIV status"
        ]
      ],
      "remaining_reference_features": [
        "6-minute Walk Distance",
        "Borg Dyspnea Index",
        "Height",
        "Weight"
      ],
      "remaining_candidate_features": [
        "Age",
        "Region of Enrollment",
        "Concomitant PAH therapy"
      ]
    }
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "##Answer:\nAge, Continuous, Gender, Ethnicity (NIH/OMB), Region of Enrollment, Body Mass Index, Systolic Blood Pressure, Diastolic Blood Pressure, Pulmonary Arterial Hypertension (PAH) diagnosis duration, World Health Organization (WHO) functional class, Six-minute walk distance, Borg dyspnea index,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Sex: Female",
          "Gender"
        ],
        [
          "Race/Ethnicity",
          "Ethnicity (NIH/OMB)"
        ],
        [
          "Years Pulmonary Arterial Hypertension (PAH) Present",
          "Pulmonary Arterial Hypertension (PAH) diagnosis duration"
        ],
        [
          "6-minute Walk Distance",
          "Six-minute walk distance"
        ],
        [
          "Borg Dyspnea Index",
          "Borg dyspnea index"
        ],
        [
          "World Health Organization Class",
          "World Health Organization (WHO) functional class"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Primary Diagnosis",
        "Height",
        "Weight"
      ],
      "remaining_candidate_features": [
        "Age",
        "Region of Enrollment",
        "Body Mass Index",
        "Systolic Blood Pressure",
        "Diastolic Blood Pressure"
      ]
    }
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, ethnicity, weight, height, body mass index (BMI), medical history of pulmonary arterial hypertension, HIV status, conventional therapy for PAH, duration of PAH diagnosis, New York Heart Association (NYHA) functional class, six-minute walk distance (6MWD) at baseline, mean pulmonary arterial pressure (mPAP) at baseline, cardiac output at baseline, pulmonary vascular resistance (PVR) at baseline.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Race/Ethnicity",
          "race"
        ],
        [
          "Race/Ethnicity",
          "ethnicity"
        ],
        [
          "Years Pulmonary Arterial Hypertension (PAH) Present",
          "duration of PAH diagnosis"
        ],
        [
          "6-minute Walk Distance",
          "six-minute walk distance (6MWD) at baseline"
        ],
        [
          "Height",
          "height"
        ],
        [
          "Weight",
          "weight"
        ],
        [
          "Primary Diagnosis",
          "medical history of pulmonary arterial hypertension"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Borg Dyspnea Index",
        "World Health Organization Class"
      ],
      "remaining_candidate_features": [
        "Age",
        "body mass index (BMI)",
        "HIV status",
        "conventional therapy for PAH",
        "New York Heart Association (NYHA) functional class",
        "mean pulmonary arterial pressure (mPAP) at baseline",
        "cardiac output at baseline",
        "pulmonary vascular resistance (PVR) at baseline"
      ]
    }
  }
}